The Latest

  • A patient on a stretcher in a hospital corridor interacts with a doctor.
    Image attribution tooltip
    Courtesy of AdventHealth
    Image attribution tooltip

    FDA seeks input on telesurgery, autonomous robotics

    The agency is inviting public comment on a new discussion paper as it prepares to shape policy covering robotic medical devices with autonomous or remote teleoperation functions.

    FDA
  • Aerial view of turquoise ocean waves breaking over a shallow, rocky coral reef.
    Image attribution tooltip

    Getty Images / Andrey Danilovich

    Image attribution tooltip
    Sponsored by Baker Tilly US

    Find opportunity in a shifting life sciences market

    See where capital and deal activity are moving, with insights to inform stronger investment, growth and strategic decisions.

    M&A
  • A picture of Getinge's headquarters building in Gothenburg, Sweden.
    Image attribution tooltip
    Courtesy of Getinge
    Image attribution tooltip

    Getinge hires president of acute care therapies

    Stacy Beske joins Getinge from Philips and will take over the role on Dec. 1.

  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Novocure denied FDA approval for metastatic cancer treatment

    The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.

    FDA
  • A picture of the exterior of a Labcorp building.
    Image attribution tooltip
    Courtesy of Labcorp
    Image attribution tooltip

    Labcorp completes $375M Millennium Health takeover

    The deal, which includes a $245 million upfront fee, expands the geographic reach of Labcorp’s drug testing business.

  • A headshot of Solomon Moshkevich
    Image attribution tooltip
    Permission granted by Natera
    Image attribution tooltip

    Natera promotes Solomon Moshkevich to CEO

    The CEO change was unexpected and prompted a stock selloff Friday, analysts said, but the new chief executive is prepared for the role.

  • A picture of San Francisco's Coit Tower and downtown at dawn.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Top medtech conferences in 2027

    From AdvaMed’s meeting in San Francisco to a robotics conference in Rome, next year’s calendar is already filled with medtech events to attend.

    Updated Nov. 6, 2026
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers to rebrand and separate its IVD business

    The company is rebranding the unit as Olyrian Diagnostics and plans to set it up as a standalone business by mid-2028.

  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem Diabetes Care names next CEO

    Jeannette Bankes will take over the role from John Sheridan, who will retire at the end of the year after leading the company since 2019.

  • A concrete sign outside of a building reads "Department of Health & Human Services" wrapped around the HHS logo.
    Image attribution tooltip
    Kayla Bartkowski via Getty Images
    Image attribution tooltip

    Medicare will cut billions from 340B, expand site-neutral payments in 2027

    Regulators finalized a rule Wednesday that would slash payments for drugs in the controversial 340B program and equalize some payments between care sites. Hospitals railed against the rule.

  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards bumps up sales forecast on TAVR strength in Q3

    Going forward, the heart valve maker expects procedure volumes to rise following positive study data and expanded Medicare reimbursement.

  • A doctor and patient in the cath lab.
    Image attribution tooltip
    Image Supply via Getty Images
    Image attribution tooltip

    3 takeaways from TCT 2026

    Edwards’ TAVR results in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation and Abbott’s left atrial appendage closure devices also produced positive study findings.

  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific, Blackstone agree to $455M deal to co-fund heart pump development

    As part of the agreement, Blackstone may receive regulatory and commercial milestone payments, plus royalties on net sales. 

  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed names David Segal chief medical officer

    Segal is succeeding Robert Vigersky, who is transitioning to a chief medical officer emeritus role ahead of his planned retirement at the end of next year.

  • A sign for Zimmer Biomet is shown outside of the company's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer raises sales forecast despite slower knee business

    CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did last week.

  • App icons for generative AI assistants OpenAI ChatGPT, Google Gemini, Anthropic Claude, DeepSeek, Meta AI and xAI Grok are pictured on a smartphone screen.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    How should the FDA regulate generative AI in medtech? Here are 5 takes

    Patients, providers and medtech firms submitted hundreds of comments to the Food and Drug Administration on how the agency should approach generative AI in medical devices.

    FDA
  • Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    Philips settles with DOJ over recalled CPAP machines

    Philips will pay 288 million euros to settle an investigation related to its recall of millions of sleep and respiratory devices.

  • MRI machine
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Bracco invests $230M to build US plant for injectable contrast media

    The Sanford, North Carolina, facility will become the company’s first manufacturing site for injectable contrast media in the U.S.

  • A person stands at a podium and speaks.
    Image attribution tooltip
    Permission granted by Resmed
    Image attribution tooltip
    Q&A

    AdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industry

    In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of Resmed, shared a bird’s eye view of the issues.

  • Image of healthcare equipment
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    AI vendors, health systems join physicians in liability for clinical AI: AMA

    The AMA's new issue brief assigns distinct responsibilities to physicians, developers and healthcare organizations, arguing that protecting patients requires accountability from all stakeholders.

    AI
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott starts pivotal trial for mitral valve replacement device

    The study is testing a device that Abbott executives believe can expand the mitral valve market.

  • Modern office building with tall glass windows and palm trees lining the entry drive. A large white and green sign in the foreground reads “Dexcom” with the number “6350” below. Surrounding the sign are colorful landscaping features including small bushes, flowers, and a mulched bed. Cars and flags are visible in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansion

    Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 diabetes. Competitor Dexcom, however, did not experience the same slowdown.